Max Dawson
Chief Operating Officer at DermBiont, Inc.
Profile
Max N.
Dawson is currently the Chief Operating Officer at DermBiont, Inc. He previously worked as the Head-Program Finance at Vertex Pharmaceuticals, Inc., an Analyst-Finance & Operations at Merck KGaA, the Head-Business Development at Dyax Corp., and the Vice President-Business Development at Adagene, Inc. He holds an MBA from Babson College and an undergraduate degree from Bates College.
Max Dawson active positions
| Companies | Position | Start |
|---|---|---|
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Chief Operating Officer | 31/08/2019 |
Former positions of Max Dawson
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
| ADAGENE INC. | Corporate Officer/Principal | - |
Training of Max Dawson
| Babson College | Masters Business Admin |
| Bates College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| MERCK KGAA | Health Technology |
| Private companies | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Commercial Services |
- Stock Market
- Insiders
- Max Dawson